InspireMD

NSPR65

Penny Stock

$2.65arrow_drop_up2.32%$0.06

Penny Stock

NSPR65

$2.65

arrow_drop_up2.32%$0.06

Penny Stock

Performance History

Key Stats
Open	$2.65
Prev. Close	$2.58
EPS	-0.71
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$69.12M
PE Ratio	-

	LOW	HIGH
Day Range	2.52	2.67
52 Week Range	1.81	3.85

Ratios







EPS	-0.71

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About InspireMD (NSPR)

InspireMD Inc (NSPR) is a medical device company that specializes in the development and commercialization of proprietary stent systems for the treatment of cardiovascular diseases. The company is dedicated to providing innovative and effective solutions for physicians and patients worldwide. With a focus on reducing complications and improving patient outcomes, InspireMD is revolutionizing the treatment of complex lesions in coronary and peripheral artery disease.

The stock price history of InspireMD Inc (NSPR) reflects the company's growth and potential. Over the years, the stock has witnessed promising upward trends, driven by the advancements in its stent systems and expanding market reach. Investors who have been involved with NSPR have had the opportunity to benefit from the company's success. Continual growth and investment in research and development have allowed InspireMD Inc to maintain a competitive edge in the industry.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Marvin L. Slosman
Headquarters: Tel Aviv
Employees: 55
Exchange: NASDAQ

Keep an eye on InspireMD

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is InspireMD 's (NSPR) price per share?

The current price per share for InspireMD (NSPR) is $2.65. The stock has seen a price change of $0.06 recently, indicating a 2.33% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for InspireMD (NSPR)?

For InspireMD (NSPR), the 52-week high is $3.85, which is 45.28% from the current price. The 52-week low is $1.81, the current price is 46.41% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is InspireMD (NSPR) a growth stock?

InspireMD (NSPR) has shown an average price growth of -6.03% over the past three years. It has received a score of 73 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying InspireMD as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is InspireMD (NSPR) stock price performance year to date (YTD)?

As of the latest data, InspireMD (NSPR) has a year-to-date price change of -2.21%. Over the past month, the stock has experienced a price change of 6.43%. Over the last three months, the change has been -7.02%. Over the past six months, the figure is 13.73%. Looking at a longer horizon, the five-year price change stands at -78.25%.

help

Is InspireMD (NSPR) a profitable company?

InspireMD (NSPR) has a net income of -$19.92M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 29.12% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -467.51% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6.2M, with a revenue growth rate of 20%, providing insight into the company's sales performance and growth. The gross profit is $1.81M. Operating income is noted at -$21.14M. Furthermore, the EBITDA is -$29.68M.

help

What is the market capitalization of InspireMD (NSPR)?

InspireMD (NSPR) has a market capitalization of $69.12M. The average daily trading volume is 2.62, indicating the stock's liquidity and investor engagement.

News

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System

CALENDAR OF EVENTS

PRODUCT / SERVICES ANNOUNCEMENT

May 28, 2024

InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024

May 6, 2024

Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates

CLINICAL STUDY

Mar 26, 2024

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

EARNINGS RELEASES AND OPERATING RESULTS

Mar 6, 2024

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About InspireMD (NSPR)

Keep an eye on InspireMD

Frequently Asked Questions

What is InspireMD 's (NSPR) price per share?

What is the 52-week high and low for InspireMD (NSPR)?

Is InspireMD (NSPR) a growth stock?

What is InspireMD (NSPR) stock price performance year to date (YTD)?

Is InspireMD (NSPR) a profitable company?

What is the market capitalization of InspireMD (NSPR)?

News

Take Your Investments to a Whole New Level